The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Power List / 2026 / Power List / Osama Khan

Osama Khan

Staff Pathologist, San Carlos California, USA

  • Q&A

About Osama Khan

What does the future of laboratory medicine look like, and how are you helping to future-proof your department?

As a pathologist, I am passionate about advancing cancer diagnostics and have been fortunate to pursue this interest over the past few years. Working as a staff anatomical pathologist in molecular residual disease (MRD) testing at Natera has allowed me to review patient samples and contribute information that may guide treatment decisions.

MRD testing is a rapidly developing field in which many pathologists have limited exposure or formal training. Gaining experience in this area has therefore been an invaluable opportunity to expand my skills as an early-career pathologist.

One of my major accomplishments since joining the company has been leading the digitization of our MRD workflow. This involved implementing and validating a digital pathology platform while working closely with cross-functional stakeholders and industry specialists. I collaborated with fellow pathologists, laboratory operations, product teams, histotechnologists, laboratory aides, and other team members to successfully implement this transformation. The project enabled us to accommodate a higher volume of patient samples, improve accuracy, and reduce turnaround times. This was particularly meaningful because cancer patients and their providers are often eagerly awaiting these test results to either re-initiate treatment or de-escalate therapy if cancer cells are undetectable.

I’ve also been involved in the validation and implementation of IHC biomarkers into our workflow. This initiative also required the transition to a new digital pathology platform and the implementation of a new image management system. One of the most exciting areas I have championed through these efforts has been the integration of AI into our sample review processes, including tumor purity assessment and biomarker scoring.

Through these experiences, I have progressed into the role of digital pathology lead, helping to advance digital and AI-enabled pathology within the company. This includes evaluating emerging technologies that could improve efficiency, diagnostic accuracy, and patient care.

Another of my interests is medical and pathology education. Over the past few years, I have worked with pathologists, sample review teams, and communications colleagues to develop an educational series for clinicians and laboratory professionals. This work has included presentations at regional and international conferences, in-person teaching, and webinars on molecular residual disease testing. The sessions also explore how pathologists and other laboratory professionals can support its appropriate use in patient care.

Combining pathology, education, and emerging diagnostic technologies has been highly rewarding. I look forward to continuing my development as a pathologist and contributing to the future of cancer diagnostics.

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Explore Pathology Infectious Disease

The Viral Frontier

January 23, 2024

1 min read

Explore Pathology Genetics and epigenetics

Breathing New Life into Diagnostics

January 22, 2024

6 min read

Explore Pathology Analytical science

Opening a Window into Brain Trauma

January 18, 2024

4 min read

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.